ISRCTN83743312CompletedNot Applicable
Concerted Action Polyp Preventio
ewcastle upon Tyne Hospitals NHS Trust (UK)0 sites400 target enrollmentStarted: September 15, 2005Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 400
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Known carriers of familial adenomatous polyposis (FAP), either by molecular genetic analysis or by phenotypic features
- •2. Over 10 years of age with an intact colon
Exclusion Criteria
- •1. Already taking Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- •2. Partial Resection
- •3. If over 21 years of age - to take treatment for 1 year only
Investigators
Similar Trials
Completed
Not Applicable
COnteMporary strategy For aORToiliac intervention registryPatients with peripheral artery disease (PAD) associated with AI: aorto-iliacJPRN-UMIN000043721Japan Endovascular Treatment Conference1,000
Terminated
Phase 3
Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon CancerColorectal CancerNCT00087256NSABP Foundation Inc18
Not yet recruiting
Unknown
The effect of a single high-fat meal and the protective effect of naturally occurring polyphenolic compounds on artery functioACTRN12623000655640Gary Williamson18
Not yet recruiting
Not Applicable
Complete resection rate of polyps: long follow-up studyNL-OMON21030Academic Medical Center (AMC)444
Not yet recruiting
Not Applicable
TeMpOH-3Prophylactic catheters, balloon catheters, embolisation, embolization, abnormal placentation, abnormally invasive placenta, accreta, increta, percreta.Profylactische katheters, ballonkatheters, embolisatie, abnormale placentatieNL-OMON28238Sanquin, LUMC750